Companies Urged To Tailor Approach To Orphan Drugs In Emerging Markets
Executive Summary
Extending marketing strategies for orphan drugs from the developed world to emerging markets are fraught with difficulty, and pharmaceutical companies need to adapt their business models in such countries for this increasingly popular category of new drugs.